The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients
IntroductionThis study aims to establish the fingerprint spectra of Kai-Xin-San (KXS) and investigate its spectrum-effect relationship in treating Alzheimer’s disease (AD).MethodsInitially, the fingerprints of 15 batches of KXS were established and analyzed using HPLC, with the method’s precision, s...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1538837/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832583728335945728 |
---|---|
author | Jinfu Wu Hang Sun Yiyang Zhao Lian Lian Hongsheng Bian Yong Guo Dan Li Lili Huang |
author_facet | Jinfu Wu Hang Sun Yiyang Zhao Lian Lian Hongsheng Bian Yong Guo Dan Li Lili Huang |
author_sort | Jinfu Wu |
collection | DOAJ |
description | IntroductionThis study aims to establish the fingerprint spectra of Kai-Xin-San (KXS) and investigate its spectrum-effect relationship in treating Alzheimer’s disease (AD).MethodsInitially, the fingerprints of 15 batches of KXS were established and analyzed using HPLC, with the method’s precision, stability, and repeatability thoroughly evaluated. Subsequently, the effects of the 15 batches of KXS were assessed in an olfactory escape memory experiment, utilizing Aβ42 transgenic drosophila as a model. Finally, the spectrum-effect relationship between the KXS fingerprint and memory improvement was analyzed, with the active ingredients subjected to validation testing.ResultsThe results identified seventeen common peaks in the fingerprint, and eight active components were determined: polygalaxanthone III, 3-6-disinapoylsucrose, ginsenoside Rg1, ginsenoside Rb1, β-asarone, α-asarone, dehydrotumulosic acid, and dehydropachymic acid. Treatment with KXS (1%, for 4 days) significantly enhanced the performance index of Aβ42 flies in the olfactory experiment. Both spectrum-effect analysis and validation tests indicated that polygalaxanthone III, ginsenoside Rg1, ginsenoside Rb1, β-asarone, and α-asarone were positively correlated with the performance index and improved the performance index in the olfactory experiment. The HPLC fingerprint method for KXS demonstrated excellent precision, accuracy, and reproducibility, making it suitable for quality evaluation and control of KXS. Polygalaxanthone III, ginsenoside Rg1, ginsenoside Rb1, β-asarone, and α-asarone are identified as potential active ingredients of KXS for anti-AD effects.DiscussionThese findings provide an experimental basis for developing new drugs based on KXS and its active ingredient combinations. |
format | Article |
id | doaj-art-8ee7590d69034a8cb4dc17f344007f54 |
institution | Kabale University |
issn | 1663-9812 |
language | English |
publishDate | 2025-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Pharmacology |
spelling | doaj-art-8ee7590d69034a8cb4dc17f344007f542025-01-28T06:41:26ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011610.3389/fphar.2025.15388371538837The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredientsJinfu Wu0Hang Sun1Yiyang Zhao2Lian Lian3Hongsheng Bian4Yong Guo5Dan Li6Lili Huang7College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaShineway Pharmaceutical Group Co., Ltd., Shijiazhuang, ChinaShineway Pharmaceutical Group Co., Ltd., Shijiazhuang, ChinaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaIntroductionThis study aims to establish the fingerprint spectra of Kai-Xin-San (KXS) and investigate its spectrum-effect relationship in treating Alzheimer’s disease (AD).MethodsInitially, the fingerprints of 15 batches of KXS were established and analyzed using HPLC, with the method’s precision, stability, and repeatability thoroughly evaluated. Subsequently, the effects of the 15 batches of KXS were assessed in an olfactory escape memory experiment, utilizing Aβ42 transgenic drosophila as a model. Finally, the spectrum-effect relationship between the KXS fingerprint and memory improvement was analyzed, with the active ingredients subjected to validation testing.ResultsThe results identified seventeen common peaks in the fingerprint, and eight active components were determined: polygalaxanthone III, 3-6-disinapoylsucrose, ginsenoside Rg1, ginsenoside Rb1, β-asarone, α-asarone, dehydrotumulosic acid, and dehydropachymic acid. Treatment with KXS (1%, for 4 days) significantly enhanced the performance index of Aβ42 flies in the olfactory experiment. Both spectrum-effect analysis and validation tests indicated that polygalaxanthone III, ginsenoside Rg1, ginsenoside Rb1, β-asarone, and α-asarone were positively correlated with the performance index and improved the performance index in the olfactory experiment. The HPLC fingerprint method for KXS demonstrated excellent precision, accuracy, and reproducibility, making it suitable for quality evaluation and control of KXS. Polygalaxanthone III, ginsenoside Rg1, ginsenoside Rb1, β-asarone, and α-asarone are identified as potential active ingredients of KXS for anti-AD effects.DiscussionThese findings provide an experimental basis for developing new drugs based on KXS and its active ingredient combinations.https://www.frontiersin.org/articles/10.3389/fphar.2025.1538837/fullKai-Xin-Sanspectrum-efficacy relationshipAlzheimer’s diseasepharmacodynamic material basisHPLCAβ42 transgenic Drosophila |
spellingShingle | Jinfu Wu Hang Sun Yiyang Zhao Lian Lian Hongsheng Bian Yong Guo Dan Li Lili Huang The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients Frontiers in Pharmacology Kai-Xin-San spectrum-efficacy relationship Alzheimer’s disease pharmacodynamic material basis HPLC Aβ42 transgenic Drosophila |
title | The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients |
title_full | The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients |
title_fullStr | The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients |
title_full_unstemmed | The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients |
title_short | The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients |
title_sort | spectrum efficacy correlation of kai xin san for cognition of aβ42 transgenic drosophila and verification of its active ingredients |
topic | Kai-Xin-San spectrum-efficacy relationship Alzheimer’s disease pharmacodynamic material basis HPLC Aβ42 transgenic Drosophila |
url | https://www.frontiersin.org/articles/10.3389/fphar.2025.1538837/full |
work_keys_str_mv | AT jinfuwu thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT hangsun thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT yiyangzhao thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT lianlian thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT hongshengbian thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT yongguo thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT danli thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT lilihuang thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT jinfuwu spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT hangsun spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT yiyangzhao spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT lianlian spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT hongshengbian spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT yongguo spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT danli spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients AT lilihuang spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients |